It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2016.
2016 | Hyderabad, Telangana, India | ActiveBrilliant Therapeutics Private Limited, a active private limited company, was established on 03 November 2016 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33112TG2016PTC112782. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Darla Prasad (Director), Puvula Kanaka Rao (Director). Past directors included Ramaswamy Natesaiyer, Chandra Sekhar Korrapati, Dinar Kumar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Fifth Floor,T.G.V. Mansion,6-2-1012 Rajbhavan Road Khairatabad, Hyderabad, Telangana, 500004.
U33112TG2016PTC112782
112782
03 November 2016
₹5.00 Cr
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Brilliant Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Darla Prasad | Director | 05 Oct 2019 | Current |
| Puvula Kanaka Rao | Director | 30 Mar 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Oct 2018 | Past |
| Pramod Abcsdd | Director | 05 Oct 2019 | Past |
| Pramod Abcsdd | Director | 30 Mar 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Brilliant Therapeutics Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Brilliant Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Brilliant Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Brilliant Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brilliant Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Brilliant Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Brilliant Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity Darla Prasad was appointed as a Director was appointed as a Director on 05 Oct 2019 & has been associated with this company since 6 years 1 month . was completed.
Progress on Puvula Kanaka Rao was appointed as a Director was appointed as a Director on 30 Mar 2017 & has been associated with this company since 8 years 8 months . was documented.
Brilliant Therapeutics Private Limited was registered on 03 Nov 2016 with Roc Hyderabad & aged 9 years 28 days as per MCA records. was recorded as a recent event.
The CIN of Brilliant Therapeutics Private Limited is U33112TG2016PTC112782.
Brilliant Therapeutics Private Limited is headquartered at Fifth Floor,T.G.V. Mansion,6-2-1012 Rajbhavan Road Khairatabad, Hyderabad, Telangana, 500004.
Brilliant Therapeutics Private Limited was incorporated on 03 November 2016.
The current directors of Brilliant Therapeutics Private Limited are
The primary industry of Brilliant Therapeutics Private Limited is Manufacturing.
Brilliant Therapeutics Private Limited is unlisted.
The authorized capital of Brilliant Therapeutics Private Limited is ₹5.00 Cr, and the paid-up capital is ₹0.10 M.
The compliance status of Brilliant Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX